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Background: Burkholderia pseudomallei is a facultative intracellular pathogen and the causative agent of
melioidosis. A conserved type III secretion system (T3SS3) and type VI secretion system (T6SS1) are critical for
intracellular survival and growth. The T3SS3 and T6SS1 genes are coordinately and hierarchically regulated by a
TetR-type regulator, BspR. A central transcriptional regulator of the BspR regulatory cascade, BsaN, activates a subset
of T3SS3 and T6SS1 loci.
Results: To elucidate the scope of the BsaN regulon, we used RNAseq analysis to compare the transcriptomes of
wild-type B. pseudomallei KHW and a bsaN deletion mutant. The 60 genes positively-regulated by BsaN include
those that we had previously identified in addition to a polyketide biosynthesis locus and genes involved in amino
acid biosynthesis. BsaN was also found to repress the transcription of 51 genes including flagellar motility loci and
those encoding components of the T3SS3 apparatus. Using a promoter-lacZ fusion assay in E. coli, we show that
BsaN together with the chaperone BicA directly control the expression of the T3SS3 translocon, effector and
associated regulatory genes that are organized into at least five operons (BPSS1516-BPSS1552). Using a mutagenesis
approach, a consensus regulatory motif in the promoter regions of BsaN-regulated genes was shown to be essential
for transcriptional activation.
Conclusions: BsaN/BicA functions as a central regulator of key virulence clusters in B. pseudomallei within a more
extensive network of genetic regulation. We propose that BsaN/BicA controls a gene expression program that
facilitates the adaption and intracellular survival of the pathogen within eukaryotic hosts.Background
Melioidosis is a serious and often fatal infectious disease
common to Southeast Asia and Northern Australia caused
by the Gram-negative soil bacterium Burkholderia pseudo-
mallei. B. pseudomallei is a highly versatile pathogen cap-
able of surviving inside mammalian cells and in many
environmental niches. The bacterium can infect numerous
animal species, amoebae, nematodes, and tomato plants
[1-5], and has been previously found within the tissues of
exotic grasses in Australia [6]. The environmental origin
of B. pseudomallei and its promiscuous host range have
shaped the hypothesis that some of its genetic loci evolved* Correspondence: yunn_hwen_gan@nuhs.edu.sg
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unless otherwise stated.in the rhizosphere as anti-predation determinants that
subsequently promote “accidental” virulence in humans
and animals. In recent years, important advances have
been made in understanding the pathogenic mechanisms
of B. pseudomallei including the roles of the Type III
and Type VI Secretion Systems (T3SS, T6SS) [7-11].
B. pseudomallei contains three T3SSs and six T6SSs,
but only T3SS3 (also referred to as the Burkholderia
secretion apparatus, or T3SSBsa) and T6SS1 are critical
for pathogenesis in mice and hamsters [7,12,13].
Expression of the T3SS3 and T6SS1 gene clusters is
tightly controlled, both temporally and spatially, during
the B. pseudomallei intracellular lifecycle. We have iden-
tified a regulatory cascade that coordinately activates
T3SS3 and T6SS1 gene expression in growth medium
and in infected mammalian cells [8,14]. At the top of the
cascade is the TetR-type regulator BspR that stimulates
the expression of bprP. The bspR gene is located ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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bprP is part of the T3SS3 gene cluster on chromosome 2
[14]. The ToxR-like BprP in turn activates genes encoding
the structural components of T3SS3, including the araC-
type regulatory gene bsaN. BsaN is important for the acti-
vation of T3SS3 effector and translocon gene expression,
and several regulatory genes including bprC and virAG,
whose gene products control T6SS1 expression [8]. The
mechanisms through which these transcriptional regula-
tors control the expression of their target genes are not
understood. It is also unclear whether these regulators are
acting directly on the identified target genes or through as
yet undiscovered intermediary regulators, and whether
additional host cell cofactors are involved that may serve
as intracellular signals.
Compared to T3SSs in other pathogens such as Pseudo-
monas, Salmonella and Shigella, only a limited number of
effectors have been identified for B. pseudomallei T3SS3.
One of the effector proteins secreted by T3SS3 is BopE,
which is annotated to exhibit guanine nucleotide exchange
factor activity and has been reported to facilitate invasion
of epithelial cells [15]. bopA is generally assumed to en-
code a T3SS3 effector since it is located adjacent to bopE,
although T3SS3-dependent secretion of BopA has never
been verified. Functionally, BopA has been described to
promote resistance to LC3-associated autophagy and a
bopA mutation results in an intracellular replication defect
[16,17]. A third effector protein, BopC (BPSS1516), was
recently shown to be secreted via T3SS3, and bopC mu-
tants were reported to be less invasive in epithelial cells
[18] and to exhibit delayed endosome escape and reduced
intracellular growth in J774 murine macrophages [19].
To determine the full extent of the BsaN regulon and
examine whether BsaN activates the expression of add-
itional effector genes, we performed global transcrip-
tome analysis of B. pseudomallei KHW wildtype (WT)
and a ΔbsaN mutant strain using RNAseq. Our analysis
shows that 111 genes are under the direct or indirect
transcriptional control of BsaN. In addition to activating
loci associated with T3SS3, we demonstrate that BsaN
functions to repress transcription of other loci. Thus,
BsaN functions as a central regulatory factor within a
more extensive network to facilitate the intracellular
lifecycle of B. pseudomallei.
Results
Identification of the BsaN regulon through RNAseq
analysis
BsaN (BPSS1546 in the reference B. pseudomallei K96243
genome) was previously shown to function as a central
regulator of a hierarchical cascade that activates effector
and translocon genes of T3SS3 as well as several asso-
ciated regulatory genes [8,14]. Furthermore, BsaN was
shown to activate the expression of certain T6SS1-associated genes including the two-component regula-
tory system locus virAG (BPSS1494, 1495), and the bim
actin motility genes (BPSS1490-1493). To gain further
insight into the BsaN regulon, massive parallel sequen-
cing was performed on cDNA prepared from RNA iso-
lated from wild-type and ΔbsaN mutant strains. We
had previously shown that complementation of our
ΔbsaN mutant with a bsaN plasmid could restore the
secretion of the BopE effector [14], showing that our
complementation restored protein expression of the
effectors and that the mutation was specific to bsaN
and not due to off target effects.
Between 16 and 56 million reads (n = 2 from 3 com-
bined cultures) were obtained that aligned to non-
ribosomal genes in the KHW [20] genome (Additional
file 1: Table S1). Reads of the technical replicates dis-
played high reproducibility (R-value) (Additional file 1:
Table S1) demonstrating that variability was not intro-
duced through sample preparation or sequencing er-
rors. The K96243 reference genome was co-aligned for
ease of gene annotation. The nucleotide sequences of
chromosomes I and II are 99.3 and 99.1% identical,
respectively.
Comparison between wild-type and ΔbsaN transcrip-
tomes identified 111 genes that were differentially regu-
lated using 3-fold or more (adjusted p-value < 0.01) as the
cut off. Of these, 60 genes were expressed more highly in
wild-type KHW compared to the ΔbsaN strain, indicating
that BsaN directly or indirectly activates their transcrip-
tion (Table 1). However, 51 genes were expressed more
highly in the ΔbsaN mutant suggesting that BsaN can
function directly or indirectly as a repressor (Table 2).
RNAseq results were validated using quantitative real
time-PCR (qRT-PCR) analysis for select loci. RNAseq ana-
lysis identified all genes that we had previously shown to
be activated by BsaN [8,14] (Figure 1A and 1B, Table 1).
The effector and chaperone genes bopE, bopA and bicP
together with the regulatory gene bprD were amongst
the highest activated genes (50-270-fold). In addition,
two putative transposase genes separating the T3SS3
genes and the T6SS1 gene clusters were highly activated
by BsaN (Table 1). Genes activated at lower levels (3-4-
fold) include a hybrid non-ribosomal peptide synthase
(NRPS)/polyketide synthase (PKS) locus consisting of
22 genes (BPSL0472-BPSL0493) unique to B. pseudomallei
and B. mallei. NRPS/PKS systems are found in microbes
and fungi, and are generally responsible for the production
of complex natural compounds such as antibiotics and
siderophores. Burkholderia species are rich in NRPS/PKS
loci that contain multiple metabolic genes or encode large
multidomain synthases [21]. Although the precise function
of this NRPS/PKS locus is not currently known, the pres-
ence of a diaminobutyrate-2-oxoglutarate amino transfer-
ase gene (BPSL0476) suggests that 2,4-diaminobutrate is
Table 1 List of 60 genes that are expressed 3-fold and higher in the wild-type versus ΔbsaN mutant strains (p < 0.01)
Gene locus ID Gene Protein description Fold activation
T3SS3 associated
BPSS1512 tssM ubiquitin-specific proteinase 9.3
BPSS1513 7.5
BPSS1514 folE GTP hydrolase 5.1
BPSS1515 9.0
BPSS1516 bopC T3SS-3 effector 48.2
BPSS1518 transposase 44.3
BPSS1519 transposase 10.1
BPSS1523 bicP T3SS-3 chaperone 149.0
BPSS1524 bopA T3SS-3 effector 269.4
BPSS1525 bopE T3SS-3 effector 51.7
BPSS1526 bapC T3SS-3 effector 5.9
BPSS1527 bapB T3SS-3 effector 6.8
BPSS1528 bapA T3SS-3 effector 7.6
BPSS1529 bipD T3SS-3 translocon 7.6
BPSS1531 bipC T3SS-3 translocon 6.3
BPSS1532 bipB T3SS-3 translocon 6.6
BPSS1533 bicA T3SS-3 chaperone 9.4
T6SS1 apparatus
BPSS1497 tssB T6SS-1 3.1
BPSS1498 hcp T6SS-1 11.3
Actin based motility
BPSS1490 N-acetylmuramoyl-L-Ala-amidase 13.5
BPSS1491 ADP-heptose:LPS transferase 8.8
BPSS1492 bimA Bim actin polymerization protein 7.8
BPSS1493 14.5
Polyketide biosynthesis
BPSL0472-BPSL0493 NRPKS/PKS biosynthesis locus 3.0-4.3
BPSL2883 Glyoxalase/bleomycin resistance protein/dioxygenase 4.0
Amino acid biosynthesis and sugar uptake
BPSL0196 metW methionine biosynthesis protein MetW 4.2
BPSL0197 metX homoserine O-acetyltransferase 3.4
BPSS1691 metZ O-succinylhomoserine sulfhydrylase 3.2
BPSS0005 kbl 2-amino-3-ketobutyrate CoA ligase 6.3
BPSS0006 tdh L-threonine dehydrogenase 5.5
BPSL1793 Periplasmic binding protein (ribose binding) 3.4
Regulatory
BPSS1494 virG T6SS-1 response regulator 22.4
BPSS1495 virA T6SS-1 His kinase 15.8
BPSS1520 bprC T3SS-3 AraC-type regulator 24.5
BPSS1521 bprD T3SS-3 regulator 151.5
BPSS1522 bprB T3SS-3 response regulator 89.5
BPSS1530 bprA T3SS-3 HNS-type regulator 6.9
BPSL0480 syrP NPKS/PKS regulator 3.9
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Table 2 List of 51 genes that are expressed 3-fold and lower in the wild-type versus ΔbsaN mutant strains (p < 0.01)









BPSL0281 flgL Flagellar hook-associated protein −3.3
BPSL3319 fliC Flagellin −3.7
BPSL3320 fliD Flagellin −3.0
BPSL3321 Unknown −3.1
Polyketide biosynthesis
BPSS0130 Non-ribosomal peptide synthase −3.1
BPSS0303-BPSS0311 PKS biosynthesis locus −3.0 - (−6.1)
BPSS0328 Malate/L-lactate dehydrogenase −7.8
BPSS0329 Fatty aldehyde dehydrogenase −9.6
BPSS0330 Amino acid transporter −19.7
BPSS0331 Dihydrodipicolinate synthase −19.0
BPSS0332 Hydroxyproline-2-epimerase −21.7
BPSS0333 Deaminating oxidase subunit −18.8
BPSS0334 Deaminating oxidase subunit −24.7





BPSS2037 Inner membrane fatty acid desaturase −3.0
BPSS2038 Acyl carrier protein −3.4
BPSS2039 Cyclopropane-fatty-acyl-phospholipid synthase −3.6
BPSS2040 Inner membrane fatty acid desaturase −3.2
Energy metabolism
BPSL1744 arcB Ornithine carbamoyltransferase −3.4
BPSL1745 arcC Carbamate kinase −3.2
BPSL2404 Periplasmic ligand binding protein −7.3
BPSL2405 FAD-dependent deaminase −5.4
BPSS1885 Aromatic hydrocarbons catabolism-related reductase −3.1
BPSS1886 Aromatic hydrocarbons catabolism-related dioxygenase −4.2
BPSS1887 Aromatic oxygenase −3.1
BPSS1888 Aromatic oxygenase −3.0
BPSL2380 cyoC Cytochrome bo oxidase subunit −3.4
BPSL2381 cyoD Cytochrome bo oxidase subunit −3.0
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Table 2 List of 51 genes that are expressed 3-fold and lower in the wild-type versus ΔbsaN mutant strains (p < 0.01)
(Continued)
Regulatory
BPSS0336 AraC-type regulator, adjacent to polyketide genes −8.1
Adaptation
BPSL3369 acoD Glycine betaine aldehyde dehydrogenase −4.0
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and threonine biosynthesis, as well as ribose uptake
(Table 2), were activated at similar levels. Representa-
tive BsaN-activated genes were confirmed by qRT-PCR
(Figure 1C-D).
Intriguingly, genes encoding the T3SS3 apparatus
components were found to be repressed in the wildtype
compared with the ΔbsaN mutant, suggesting a role for
BsaN in limiting apparatus synthesis when translocon
and effector genes are transcribed (Figure 1A, 1E, Table 2).
Also repressed are polar flagellar motility loci on chromo-
some 1 including the flagellin genes fliC and fliD, as well
as flagellar hook proteins flgL and flgK. Repression of these
genes as well as motA (BPSL3309) and cheD (BPSS3302)
were validated by qRT-PCR (Figure 1E). In Salmonella
and other bacteria, motAB are key components of the
flagellar motor complex [22]. motAB in KHW are part
of a chemotaxis (che) locus, which is repressed 2–2.9-fold
(p < 0.01) as assessed by RNAseq. In addition, expression
of a second polyketide biosynthesis locus (BPSS0303-
BPSS0311) was reduced in a ΔbsaN mutant, possibly by
repression of a co-localized araC-type regulatory gene,
BPSS0336 (Table 2). However, down-regulation of this
cluster could not be verified by qRT-PCR (data not
shown). We were likewise unable to validate repression
of BPSL2404-2405, which putatively encode transport
and energy metabolism functions, respectively, in addition
to BPSS1887-1888, which are postulated to encode oxida-
tive enzymes for energy metabolism.
Additional loci implicated in lipid and energy metab-
olism are also repressed (Table 2). Catabolic genes encode
a cytochrome o oxidase typically used by bacteria in an
oxygen-rich environment [23], along with enzymes in-
volved in the aerobic degradation of aromatic compounds
and in the degradation of arginine. A gene involved in the
synthesis of betaine, an osmoprotectant which serves to
adapt Gram-negative bacteria to conditions of high osmo-
larity, is also repressed by BsaN.
BsaN together with chaperone BicA directly activate
T3SS3 effector and T6SS1 regulatory genes
We have previously shown that expression of the two
component regulatory system virAG and the genes from
BPSS1520 (bprC) to BPSS1533 (bicA) in the T3SS3 cluster
were regulated by BsaN in concert with the chaperoneBicA [14]. To determine whether BsaN/BicA activate
these genes directly, bsaN and bicA open reading frames
(orfs) from B. pseudomallei strain KHW were inserted
into a plasmid downstream of an arabinose-inducible pro-
moter on pMLBAD [24]. These constructs were intro-
duced into E. coli DH5α [25] along with an additional
construct containing putative promoter regions of several
BsaN target genes transcriptionally fused to lacZ on
pRW50 [26] or pRW50mob, which contains the oriT
fragment for pOT182 [27]. The effect of BsaN/BicA on
promoter activity was then assessed by β-galactosidase
activities.
The putative bsaN orf is annotated in the B. pseudomal-
lei genome database to initiate from a GTG start codon
[28]. We identified a second potential start codon (ATG)
and ribosome binding site 117 nucleotides (nt) upstream
of GTG (Figure 2A, B). bsaN/bicA expression constructs
(Figure 2A) that were initiated from GTG were unable to
activate transcription of bicA, bopA and bopE in E. coli
(Additional file 1: Table S2), supporting the notion
that the ATG was the actual start codon for BsaN.
Furthermore, a transcriptional start site was identified
56 nucleotide upstream of the ATG codon via RNA
ligase-mediated rapid amplification of cDNA ends (RLM-
RACE) (Figure 2B). A putative Ribosomal Binding Site
(RBS) is located in front of the ATG condon. Replacing
the GTG-initiated bsaN orf with the longer version
containing the ATG start site resulted in activation of
the bicA, bopA and bopE promoters as well as those for
BPSS1521 (bprD), BPSS 1495 (virA) and the putative
transposase BPSS1518 (Figure 3A-F). Expression of BsaN
alone was not sufficient to activate these promoters
(Additional file 1: Table S2), demonstrating the co-
requirement for BicA. No apparent BsaN/BicA-dependent
promoter activity was obtained for BPSS1528 (bapA),
BPSS1523 (bicP), BPSS1530 (bprA), or BPSS1520 (bprC)
(Additional file 1: Table S2) (refer to Figure 2C for gene
location). Furthermore, BsaN/BicA could not activate
transcription of a BPSS1512 (tssM)-lacZ fusion in E. coli
(Figure 3G). Thus, BsaN/BicA drives the expression of
bprDC and the BPSS1518-1516 operons directly, whereas
bicP and bprB gene expression is likely driven by the
upstream-located bopA promoter. Transcription of the
bapABC and bprA genes could be driven from the bicA
promoter. Collectively, these results are represented in
Figure 1 Regulation of selected genes by BsaN as analyzed by RNAseq and qRT-PCR. A. Activation and repression of T3SS3 cluster genes
as analyzed by RNAseq. The adjusted p value for all genes is less than 0.01 with the exception of three genes denoted with ^. B. Activation of
BsaN regulated T6SS1 and bim motility genes as analyzed by RNAseq. C and D qRT-PCR validation of selected activated genes. Expression of each
in wild-type B. pseudomallei KHW gene is set to 1; transcription was normalized to that of the recA reference gene. E. qRT-PCR validation of
repressed genes. Expression of each in wild-type B. pseudomallei KHW gene is set to 1; transcription was normalized to that of the 16S rRNA
reference gene. The flgL gene is located upstream and in the same transcriptional unit as flgK.
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Figure 2 Transcriptional analysis of bsaN and BsaN/BicA-regulated genes. A. Schematic diagram of the bsaN gene. Arrow above +1 indicates the
transcriptional start site and direction. Double-headed arrows indicated the DNA fragments used for the reconstitution of BsaN-mediated promoter
activation experiments. B. Promoter region indicating the transcriptional start site and start codon of bsaN. Bold and underlined letter G indicates the
transcriptional start site (+1 in 2A). Bold and underlined agga indicate the putative RBS. Bold and underlined ATG and GTG indicate the actual and
wrongly annotated start codons of bsaN, respectively. C. Genetic and transcriptional organization of T3SS3 genes. Arrows indicate transcriptional units.
Putative promoter regions are depicted as shaded spheres at the beginning of line arrows. Red line arrows denote operons regulated by BprP. Black
line arrows indicate operons regulated by BsaN. Black dotted arrows with shaded diamonds represent putative promoters that were analyzed for direct
activation by BsaN/BicA, however, no expression was found (Additional file 1: Table S2).
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structures controlled directly by BsaN/BicA are depicted
by black solid line arrows.
Identification of transcriptional start sites and the
sequence motif for BsaN/BicA activation
Similarities between BsaN/BicA regulated promoters were
examined by first determining their transcriptional start
sites using RLM-RACE. One transcriptional start site was
identified for the bicA, bprD and BPSS1518 promoters,
and two start sites were detected for the bopA and virA
promoters. We were unable to identify a transcriptional
start site for bopE, which is divergently transcribed from
bopA (Figure 2C). A 150-bp sequence upstream of eachtranscriptional start site was submitted to MEME (Motif
Elicitation for Prediction of DNA Motifs), which identified
a 15 bp motif that we designated as the putative BsaN box
(Figure 4A). The distance from the transcriptional start
site varied from 24 bp (virA) to 35 bp (bicA and bopA)
(Figure 4B). When the motif was submitted to Motif
Alignment & Search Tool (MAST) to search for other
potential BsaN/BicA-regulated promoters in the B.
pseudomallei genome (strain K96243), BsaN boxes were
also found upstream of tssM and BPSS1889, a putative
gene encoding an AraC family protein, in addition to
those already identified. However, qRT- PCR analysis of
BPSS1889 expression in ΔbsaN and ΔbicA mutants did
not reveal a decrease in expression compared to wild-
Figure 3 Activation of promoters by BsaN/BicA in E. coli. The ability of BsaN and BicA to directly activate the expression of promoters was
examined by providing regulatory genes in trans and measuring β-galactosidase activities arising from the expression of transcriptional promoter-lacZ
fusions in E. coli DH5α. Effect of BsaN/BicA on the expression of A. PbicA-lacZ fusion, B. PbopA-lacZ fusion, C. PbopE-lacZ fusion, D. PbprD-lacZ fusion
and E. Ps1518-lacZ fusions; Ps1518 denotes the promoter region of BPSS1518. Effect of BsaN/BicA on the expression of F. PvirA-lacZ fusion and
G. PtssM-lacZ fusion. *p < 0.05.
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jacent but transcribed in the opposite direction to the
operon BPSS1884-1888, which was shown by RNAseq
to be repressed by BsaN (Table 2). Although we could
not confirm BsaN-dependent regulation of BPSS1889
by qRT-PCR, the upstream BsaN box suggests the pos-
sible involvement of this putative regulator in repres-
sion of the operon in vivo. It is likely that conditions forBsaN-dependent repression are difficult to establish
in vitro resulting in variability and lack of validation.
We also could not identify any −10 and −35 sequences
for prokaryotic housekeeping sigma factor in these
promoters. It is likely that the BsaN/BicA-regulated
promoters are transcribed by one or more alternative
sigma factors. Unfortunately, B. pseudomallei genome
harbours more than 10 alternative sigma factors that
Figure 4 Sequence motifs in promoter regions of BsaN/BicA-regulated genes. A. The sequence motif for the BsaN box as indicated in bold, capital
letters was identified using the bioinformatics tool MEME. B. The sequence of the BsaN box generated by MEME from the 5 BsaN-activating promoters as
denoted in capital letters. The 3’capitalized letters denote the start of transcription with the exception of PtssM, which is the translational start codon of TssM.
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recognition sequences are currently unknown.
tssM is one of the highly activated genes in our RNAseq
analysis (Table 1) confirming previous in vivo expression
studies [29]. However, despite the presence of the BsaN
box upstream of the putative tssM operon (BPSS1512-
1514), BsaN/BicA alone is not sufficient to activate tssM
transcription in E. coli (Figure 3G). This suggests that tssM
regulation is more complex and likely requires additional
cis and/or trans-acting regulatory elements for activation.
Determining the sequence motif requirement for
BsaN/BicA activation
To determine whether the putative BsaN box motif was
required and sufficient for the other genes regulated
by BsaN/BicA, we constructed two types of truncated
promoter-lacZ fusions. The “type 1” deletion contained
only the BsaN motif and lacked all upstream sequences.
The “type 2” deletion lacked all upstream sequences in
addition to the first six bp of the putative BsaN box motif.
We assayed the ability of these truncated promoters to
drive lacZ expression in the presence of BsaN/BicA. All
truncated versions of the promoter regions for bicA, virA
and BPSS1518 lost promoter activity (Figure 5A-C). In
contrast, versions containing the intact BsaN box for bprD
(Figure 5D) and bopA (Figure 5E) were still functional, but
further truncation eliminated their activation. The type 1
truncated version of the bprD promoter (PbprD1-lacZ)
had three-fold higher β-galactosidase activity than the full
length promoter- lacZ fusion (PbprD-lacZ) (Figure 5D),
whereas deletion of sequences upstream of the bopApromoter did not have a significant effect on the level of
activation (Figure 5E).
BprP directly activates bsaN and bsaM
In the hierarchical control of T3SS3 and T6SS1 expres-
sion, BspR was suggested to activate the expression of
bprP [14]. Previously, BprP was shown to bind sequences
upstream of bsaM and bsaN (refer to Figure 2C for gene
location) [14], suggesting that it directly activates their
transcription. bsaN is the first orf of the putative operon
that encodes structural components of T3SS3 (Figure 2C)
and is divergently transcribed from bsaM. To better
understand how bsaN expression itself is controlled, we
examined the relationships to its upstream regulators
BspR and BprP using the LacZ fusion assay as described
previously [8]. Plasmids with either bspR or bprP under
arabinose induction control were introduced into E. coli
containing plasmids with either a bsaN-lacZ fusion or a
bsaM-lacZ fusion. A bprP-lacZ fusion served as control
for BspR regulation. The ability of BspR and BprP to
directly activate bsaN-lacZ, bsaM-lacZ and bprP-lacZ
expression was determined by measuring β-galactosidase
activity. As expected, BprP activated both the bsaM and
bsaN promoters in E. coli (Figure 6A, B). The presence of
bprQ, a gene immediate downstream from bprP, had no
effect on the activity of BprP. Furthermore, BprP did not
activate its own promoter in E. coli (data not shown).
However, BspR was not able to activate the promoter of
bprP demonstrating that this regulator is not active in
E. coli or that additional factors are required for activation
(Figure 6C).
Figure 5 (See legend on next page.)
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Figure 5 Analysis of BsaN box requirements for transcription activation by BsaN/BicA. The ability of BsaN/BicA to directly activate the
expression of truncated promoters was examined by providing regulatory genes in trans and measuring β-galactosidase activities arising from the
expression of transcriptional promoter-lacZ fusions in E. coli DH5α. The top sequence of each gene includes the intact promoter region; sequence
1 is deleted up to the BsaN box; sequence 2 also includes a 6 nucleotide deletion of the BsaN box. Effect of BsaN/BicA on the expression of
A. PbicA-lacZ fusion, B. PvirA-lacZ fusion and C. Ps1518-lacZ fusion; Ps1518 denotes the promoter region of BPSS1518. Effect of BsaN/BicA on the
expression of D. PbprD-lacZ fusion and E. PbopA-lacZ fusion.
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BsaN/BicA directly induces the expression of three known
T3SS3 effector loci, bopA, bopC and bopE. Recent studies
suggest that the T3SS3 effectors BopC and BopE are in-
volved in invasion of epithelial cells and endosome escape
[15,18,19], while BopA has been implicated in escape from
autophagy [17]. BopC was recently shown to be secreted
via T3SS3 in B. pseudomallei K96243 [18], and our
data confirm this (Additional file 1: Figure S1). In B.
pseudomallei KHW, mutation of bopA, bopC or bopE
[30] individually resulted in no detectable difference in
numbers of bacteria inside RAW264.7 mouse macro-
phages when measured 2 hr. after infection (Additional
file 1: Figure S2A). Upon extended incubation times,
however, the ΔbopA and the ΔbopACE [30] strains exhib-
ited an intracellular replication defect that was intermedi-
ate between levels observed for wildtype KHW and the
ΔbsaM [30] or ΔbsaN mutant derivatives. No differences
in intracellular growth or host cell cytotoxicity were ob-
served for the bopC or bopE mutant strains, although in-
fection with the bopA or bopACE triple deletion mutants
resulted in a decrease in cytotoxicity (Additional file 1:
Figure S2B) that coincided with a reduction in the rate of
intracellular replication (Additional file 1: Figure S2A),
suggesting that intracellular replication results in host cell
toxicity. This is in contrast to the T3SS3 ΔbsaM and the
ΔbsaN regulatory mutants in strain KHW, which are lim-
ited in their ability to multiply intracellularly as previously
reported (Additional file 1: Figure S2A).
Three BsaN/BicA-activated orfs are located between
the T3SS3 and T6SS1 loci, and upstream of the T3SS3
effector gene bopC. We analyzed these orfs for potential
roles in intracellular replication and cell-to-cell spread.
BPSS1512 encodes TssM, was previously shown to be
secreted independently of T3SS3 and T6SS1 and func-
tions as a broad-base deubiquitinase, with activity on
TNFR-associated factor-3, TNFR-associated factor-6,
and IκBα [31]. BPSS1513 is predicted to encode a short
(97 aa) protein of unknown function and was not se-
creted under our assay conditions (Additional file 1:
Figure S3A). folE (BPSS1514) encodes a putative GTP
cyclohydrolase I, suggesting a role in tetrahydrofolate
biosynthesis rather than in virulence. Consistent with
this notion, Δ(BPSS1513-folE) mutant did not exhibit
defects in cell-based virulence assays (Additional file 1:
Figure S3B-E).Discussion
T3SSs and T6SSs play important roles in bacterial-host
cell interactions [32,33]. As each system is a complex
structure encoded by 20 or more genes, it is expected
that their expression and assembly would be tightly reg-
ulated. In B. pseudomallei, T3SS3 and T6SS1 gene clus-
ters are highly induced following host cell infection [8],
and their function is critical for virulence in animal
models [8,13]. T3SS3 has been shown to promote escape
from endocytic vesicles, and T6SS1 plays a key role in
promoting intercellular spread by fusion of adjacent cell
membranes, leading to the formation of MNGCs that
can be found in melioidosis patients [34]. Upregulation
of T3SS3 is mediated by a signalling cascade initiating
from BspR through BprP, which in turn increases the ex-
pression of the AraC-type regulator BsaN. Using global
transcriptome and promoter activation analysis, we have
shown that the BsaN regulon occupies a central position
in modulating the expression of T3SS3, T6SS1 and sev-
eral additional loci that are likely involved in promoting
virulence and intracellular survival.
Regulatory factors may act to control expression by
acting directly on a given gene, or indirectly by modu-
lating a regulatory intermediate. We found that BsaN in
complex with the T3SS3 chaperone BicA directly con-
trols the expression of 19 loci in a region of chromo-
some 2 containing T6SS1 and T3SS3 accessory genes
(BPSS1494-BPSS1533). BsaN/BicA activated transcrip-
tion of the operons encoding T3SS3 effector proteins,
the BipBCD translocon complex, chaperones, and other
transcriptional regulators, as well as two genes of un-
known function (BPSS1513-1514). BsaN/BicA upregulates
expression of T6SS1 by activating the transcription of the
two component regulatory system loci virAG and bprC,
which in turn induce the hcp and tssAB loci, encoding
T6SS1 tube and sheath proteins [8,35]. Interestingly, our
RNAseq and qRT-PCR analyses revealed that BsaN also
acts to repress transcription of T3SS3 apparatus genes in
the bsaM and bsaN operons that are otherwise directly ac-
tivated by the upstream regulator BprP. It is possible that
BsaN mediates repression indirectly as the bsaM and bsaN
intergenic region lacks a recognizable BsaN binding motif
(see below). It is unlikely, however, that repression occurs
due to decreased expression of bprP since its transcription
is unchanged in a ΔbsaN mutant. Taken together, these
findings demonstrate that BsaN plays a dual role in the
Figure 6 Activation of bsaM and bsaN promoters by BprP in E. coli. The ability of BprP to directly activate the expression of promoters in the
presence and absence of BprQ was examined by providing the bprP and bprQ genes in trans and measuring β-galactosidase activities arising from
the expression of transcriptional promoter-lacZ fusions in E. coli DH5α. A. Effect of BprP and BprQ on the expression of PbsaN-lacZ fusion. B. Effect
of BprP and BprQ on the expression of PbsaM-lacZ fusion. C. Effect of BspR on the expression of PbprP-lacZ fusion. *p < 0.05.
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effector transcription, and a second in preventing costly
synthesis of T3SS3 apparatus components that are no lon-
ger required. Given the critical role of T3SS3 and T6SS1
in causing disease, BsaN/BicA could be considered a cen-
tral regulator of B. pseudomallei mammalian virulence.
Virulence studies in mice support this notion, since the
ΔbsaN mutant was unable to cause disease [8] in contrast
to the ΔbspR mutant, which produced a more chronic in-
fection in mice compared to wildtype bacteria [14].
In addition to loci associated with T3SS3 and T6SS1,
41 other genes with potential roles in virulence were also
found by RNAseq to be positively regulated by BsaN,
most notably the bimBCAD intracellular motility operon
and tssM. Regulation of bimA has been shown to be
through virAG [8], explaining why no BsaN motif was
identified for the operon. While bimA encodes an auto-
transporter protein that nucleates and polymerizes host
cell actin to facilitate intracellular motility and cell-cell
spread by the bacteria [36], the functions of the other
loci in the bim operon are unknown. TssM has been
shown to suppress host NFκB and Type I interferon
pathways [31]. TssM is expressed and secreted inside
cells following infection with B. mallei [29], however, se-
cretion occurs independently of T3SS3 and T6SS1 [31].
BsaN was also found to activate expression of a putative
non-ribosomal peptide synthase (NRPS)/polyketide syn-
thase (PKS) biosynthesis locus. The diversity of polyke-
tides, PKSs and NRPS/PKS hybrid systems was recently
reviewed by Hertweck [37]. The B. pseudomallei locus is
similar in gene content to that of a recently described
plasmid encoded NRPS/PKS system in the marine bacter-
ium Alteromonas macleodii, which was suggested to pro-
duce a bleomycin-related antibiotic Unlike A. macleodii,
the gene encoding the putative bleomycin-family resist-
ance protein (BPSL2883) is not co-localized with the
NRPS/PKS gene cluster, although they are similarly reg-
ulated by BsaN (Table 1).
BsaN is homologous to the Salmonella typhimurium
InvF, Shigella flexneri MxiE and the Yersinia enterocholi-
tica YsaB transcriptional regulators [38-40]. All belong
to the AraC/XylS family of transcriptional regulators,
which act in complex with a chaperone to activate their
respective T3SS genes. The chaperones not only serve as
cognate partners to the transcriptional activators but
also pair with T3SS translocase proteins, which are se-
creted into the host membrane to facilitate the injection
of effector proteins [41]. We currently, have no under-
standing of the timed mechanism that frees BicA and
allows it to partner with BsaN. The S. typhimurium
chaperone SicA was shown to partition the translocase
SipB and SipC, and it is sequestered by SipB [42]. Once
apparatus assembly is complete, translocases are se-
creted and SicA is free to complex and thus activateInvF. The InvF-SicA split feedback regulatory loop,
which includes positive autoregulation of invF, is con-
served in Y. enterocholitica [40]. However, in S. flexneri
MxiE-dependent activity is inhibited via sequestration
by the T3SS substrate OspD1 when the apparatus is in-
active [43]. Only when OspD1 is secreted, can MxiE part-
ner with its chaperone IpgC to activated transcription of
effector genes.
Regulation by BsaN-BicA is distinct from the previ-
ously described systems. The designation of BsaN-BicA
as a dual-function regulatory protein complex is illus-
trated by its role in activating T3SS effector and
accessory genes while repressing the system’s structural
and secretion components as summarized in Figure 7.
BsaN was also found to suppress the transcription of 51
additional genes in the B. pseudomallei genome includ-
ing those belonging to the fla1 flagellar and chemotaxis
locus on chromosome 1 (Figure 1E). Fla1 is the sole flagel-
lar system in Southeast Asian B. pseudomallei strains such
as KHW, in contrast to Australian B. pseudomallei isolates
which possess a complete second system encoded on
chromosome 2 (Fla2) [9,44]. The conserved fla1 locus
encodes polar flagella and was shown to be responsible
for swimming in liquid medium and swarming in soft
agar, but played no role in intracellular motility following
infection [9]. Moreover, we were intrigued to find that
BsaN suppresses a second PKS/NRPS cluster (BPSS0130,
BPSS0303-BPSS0311, BPSS0328-BPSS0339) (Table 2),
where almost identical homologs were identified in B.
mallei and B. thailandensis by Biggins et al. and shown to
produce an iron-chelating siderophore called malleilac-
tone [45]. Disruption of the MAL cluster in B. thailanden-
sis reduced lethality following infection of C. elegans, and
purified malleilactone was toxic to mammalian cells at mi-
cromolar concentrations. How the function of MAL fits
within an overall regulatory framework that promotes
virulence is not clear, although it is conceivable that BsaN-
mediated suppression of MAL reduces the production of
toxic products during infection, thereby promoting long
term survival within eukaryotic hosts. Alternatively, mal-
leilactone itself may regulate virulence factor production
similar to that reported for the P. aeruginosa siderophore
pyoverdine [46].
Until recently, BopA and BopE were the only two
known T3SS effector proteins in B. pseudomallei. The
dearth of effectors is surprising when compared to other
intracellular pathogens such as Shigella and Salmonella
that are known to possess numerous effectors. We have
independently identified BopC (BPSS1516) as a new
T3SS3 effector based on its regulatory control by BsaN/
BicA. bopC is transcribed in an operon encoding its
chaperone (BPSS1517) and a transposase (BPSS1518)
that are also activated by BsaN/BicA. Incidentally, we
had previously predicted by a genome-wide screen that
Figure 7 Diagram of BsaN regulon. The BsaN regulon is shown as part of a regulatory network, which is superseded by BprP activating
transcriptions of T3SS3 apparatus genes (blue) including bsaN. The bicA gene is likely initially transcribed via read through of apparatus genes.
BsaN-BicA function as a complex to activate T3SS3 translocon (purple), effector (yellow), accessory (grey) and regulatory (red) genes. Transcriptional
activation is indicated by green arrows. BsaN-BicA also activate virAG, which in turn activates the bimA motility genes and the T6SS1 locus. BprC
activates the T6SS1 tssAB apparatus genes. BsaN-BicA also activate a non-ribosomal polyketide synthesis locus and several metabolic genes.
BsaN-repressed genes as indicated by red, blunted lines include T3SS3 apparatus genes and flagellar motility genes. Only genes which have
been validated by qRT-PCR are shown.
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omic colocalization with T3SS chaperones [47]. The
BsaN regulatory motif we found in the promoters of the
effectors was also recently reported to be associated
with T3SS3 in a condition-dependent transcriptome
study [48]. Of the T3SS3-linked effector proteins; BopA,
BopC and BopE, our results suggest that BopA is the
most critical for promoting cellular infection, consistent
with prior studies linking BopA to intracellular survival
of B. pseudomallei and B. mallei [16,17,49]. No cellular
phenotype was evident following infection with ΔbopC
or ΔbopE deletion mutants, and the ΔbopACE triple ef-
fector mutant was indistinguishable from the ΔbopA
single deletion strain. As with bopE and bopC, no roles
were observed for the BsaN-regulated effector candidate
loci BPSS1513-1514 in cell-based virulence assays.
BPSS1513 encodes a hypothetical protein and BPSS1514
is annotated as folE, a predicted GTP cyclohydrolase.
Based on their genomic organization, the transcription
of these loci is likely driven from the promoter up-
stream of BPSS1512 tssM. The secretion of HA-tagged
BPSS1513 was not detected in in vitro secretion assays,
although it is possible that the epitope tag could have
interfered with secretion of BPSS1513, or that the assay
was not performed at conditions permissive for secretion.It is intriguing why these three genes are placed under
BsaN/BicA regulation by the bacterium. One possibility
could be that they are important under specific stress
conditions or during chronic infection.
Conclusions
Elucidating the scope of the BsaN regulon significantly
enhances our understanding of B. pseudomallei patho-
genic mechanisms. BsaN orchestrates the temporal and
spatial expression of virulence determinants during pro-
gression through the intracellular lifecycle, promoting en-
dosome escape and possibly evasion of autophagy through
activation of T3SS3 effector loci, facilitating cell-cell
spread by activation of T6SS1 and the bim intracellular
motility loci, and suppressing cellular immunity via the
action of the TssM ubiquitin hydrolase. BsaN also sup-
presses other loci that are potentially counterproductive
following intracellular localization, such as the fla1 fla-
gellar motility and chemotaxis locus, which could lead
to activation of cellular immunity pathways through
PAMP recognition. It is likely that the BsaN regulon
and other virulence determinants that promote patho-
genesis in higher mammals have been shaped primarily
as a result of interactions with free-living protozoa, similar
to what is believed to be the case for L. pneumophila [50].
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T3SS and T6SS, are thought to act as “anti-predation de-
terminants” that facilitate endosome escape and promote
survival within bacteriovorus amoebae by manipulating
eukaryotic pathways that are conserved from protists to
humans [3]. The dual regulatory roles of BsaN – that of
an activator and a suppressor – indicate that it is a key
node in a regulatory program that successfully enables an
environmental saprophyte to transition from the soil to
surviving intracellularly.Methods
Bacterial strains and culture conditions
Bacterial strains are listed in Table 3. Plasmids are listed in
Table 4 and Additional file 1: Table S2. The B. pseudomal-
lei wild-type strains used in this study are clinical isolates
KHW. Plasmids were introduced into E. coli DH5α and
S17-1 [51] strains by electro- or chemical-transformation.
Plasmids were transferred into B. pseudomallei by con-
jugation from E. coli S17-1 on membrane filters. E. coli
donors and B. pseudomallei recipients were first mixed
on filters and incubated at 37°C on non-selective Luria-
Bertani (LB) agar for 3 hours before transferring the filters
onto selective media. In our RNA isolation for transcrip-
tome analysis and qRT-PCR, B. pseudomallei wild-type
and mutant strains were cultured in acidic (pH 5.0) RPMI
medium containing 10% fetal bovine serum at 37°C for
4 hours, when bacteria were in their mid exponential
growth phase (OD600 ~ 1.0). Acidification results in higher
T3SS3 expression without affecting cell growth.Table 3 List of strains used in this study




S17-1 Donor strain for conjugation [51]
B. pseudomallei
KHW Clinical strain [20]
ΔbsaN KHW, bsaN orf was deleted [14]
ΔbsaM KHW, bsaM orf was deleted [30]
ΔbopA KHW, bopA orf was replaced by zeocin
resistance gene, Zeor
[30]
ΔbopE KHW, bopE orf was deleted [30]
ΔbopC KHW, bopC orf was replaced by zeocin
resistance gene, Zeor
[30]
ΔbopACE KHW, bopA and bopE orfs were deleted,
bopC orf was replaced by zeocin
resistance gene, Zeor
[30]
ΔBPSS1513-folE KHW, BPSS1513 and folE orfs were deleted This study
aAbbreviations: Zeor zeocin resistant.Bacterial mutant construction
B. pseudomallei gene deletions were generated by allelic
exchange. Approximately 1 kb fragments upstream and
downstream of the target gene were amplified from
genomic DNA and cloned into pK18mobsacB vector
[52] simultaneously using In-Fusion PCR cloning kit
(Clontech). The plasmids were introduced into B. pseu-
domallei strains by conjugation. Homologous recom-
bination was then selected for by growing bacteria in
LB + 15% sucrose to counter select the sacB gene in the
pK18mobsacB plasmid backbone. Successful double
cross-over clones were screened by colony PCR from
kanamycin sensitive colonies.
Activation of potential promoters by regulators
The ability of regulators to directly activate the expression
of promoters was examined in E. coli DH5α as described
previously [8]. Briefly, upstream regions of B. pseudomallei
genes encompassing at least 100 bp of non-coding se-
quence upstream of the start codon were amplified
from KHW genomic DNA and fused to the lacZ gene
in pRW50 or pRW50mob to generate transcriptional
fusions (Table 4). Coding sequences of regulators were
amplified from KHW genomic DNA and cloned into
the arabinose-inducible expression vector pMLBAD.
The lacZ fusion plasmid and arabinose-inducible regu-
lator plasmid were introduced into the E. coli DH5α. β-
galactosidase activities arising from the expression of
promoter-lacZ fusions were assessed. β-Galactosidase
assays were performed and values were calculated as
previously described [53].
Transcriptome analysis by RNAseq
Total RNA was extracted from three independently
grown bacterial cultures that were combined at equal
cell density in their exponential growth phase and quick
frozen in dry ice-ethanol slurry. Approximately 2 × 109
ice cold cells were centrifuged at 3000 × g for 45 sec
and 4°C and RNA was isolated from cell pellets using
the RiboPure™-Bacteria Kit (Ambion). Stable RNAs were
removed from 10 μg RNA using the MICROBExpress
kit from Ambion. Absence of genomic DNA contamin-
ation was confirmed by PCR. Paired-end libraries for
Illumina sequencing [54] were prepared using the Tru-
Seq RNA sample preparation kit version 2.0 (Illumina)
according to manufacturer's High Sample (HS) protocol
albeit omitting the initial poly A selection step. Libraries
were generated from 2 technical replicates using 350–
500 ng enriched RNA from wildtype and ΔbsaN mutant
strains as the starting material. Library preparation and
sequencing was done by the UCLA Neuroscience Genom-
ics Core (UNGC). Reads were aligned to chromosomes
I and II of B. pseudomallei KHW (also called BP22)
(RefSeq identification numbers NZ_CM001156.1 and
Table 4 List of plasmids used in this study
Plasmid Relevant characteristic(s)a Source or
reference
pMLBAD Broad host range vector containing inducible promoter Pbad, Tm
r [24]
pRW50 Low copy-number vector containing a promoter-less lacZ gene, Tcr [26]
pOT182 Source of oriT sequence, Tcr [27]
pK18mobsac Conjugative, suicide vector containing sacB gene, Kmr [52]
pRW50mob pRW50 containing oriT sequence from pOT182, Tcr This study
pMLbspR pMLBAD containing bspR orf from KHW, Tmr This study
pMLbprP pMLBAD containing bprP orf from KHW, Tmr This study
pMLbprQ pMLBAD containing bprQ orf from KHW, Tmr This study
pMLbprPQ pMLBAD containing bprP and bprQ orfs from KHW, Tmr This study
pMLbsaNs/bicA pMLBAD containing shorter bsaN orf (GTG start) and bicA orf from KHW, Tmr This study
pMLbsaN pMLBAD containing longer bsaN orf (ATG start) from KHW, Tmr This study
pMLbsaN/bicA pMLBAD containing longer bsaN orf (ATG start) and bicA orf from KHW, Tmr This study
pRWbsaM PbsaM-lacZ transcriptional fusion, pRW50mob containing bsaM upstream sequence from KHW, Tcr This study
pRWbsaN PbsaN-lacZ transcriptional fusion, pRW50mob containing bsaN upstream sequence from KHW, Tcr This study
pRWbicA PbicA-lacZ transcriptional fusion, pRW50mob containing bicA upstream sequence from KHW, Tcr This study
pRWbicA1 PbicA1-lacZ transcriptional fusion, pRW50mob containing truncated bicA upstream sequence from KHW,
type 1 deletion, Tcr
This study
pRWbicA2 PbicA2-lacZ transcriptional fusion, pRW50mob containing truncated bicA upstream sequence from KHW,
type 2 deletion, Tcr
This study
pRWbopE PbopE-lacZ transcriptional fusion, pRW50mob containing bopE upstream sequence from KHW, Tcr This study
pRWbopA PbopA-lacZ transcriptional fusion, pRW50mob containing bopA upstream sequence from KHW, Tcr This study
pRWbopA1 PbopA1-lacZ transcriptional fusion, pRW50mob containing truncated bopA upstream sequence from KHW,
type 1 deletion, Tcr
This study
pRWbopA2 PbopA2-lacZ transcriptional fusion, pRW50mob containing truncated bopA upstream sequence from KHW,
type 2 deletion, Tcr
This study
pRWbprB PbprC-lacZ transcriptional fusion, pRW50mob containing bprB upstream sequence from KHW, Tcr This study
pRWbprD PbprD-lacZ transcriptional fusion, pRW50mob containing bprD upstream sequence from KHW, Tcr This study
pRWbprD1 PbprD1-lacZ transcriptional fusion, pRW50mob containing truncated bprD upstream sequence from KHW,
type 1 deletion, Tcr
This study
pRWbprD2 PbicA2-lacZ transcriptional fusion, pRW50mob containing truncated bicA upstream sequence from KHW,
type 2 deletion, Tcr
This study
pRWbprC PbprC-lacZ transcriptional fusion, pRW50mob containing bprC upstream sequence from KHW, Tcr This study
pRWs1518 Ps1518-lacZ transcriptional fusion, pRW50 containing BPSS1518 upstream sequence from KHW, Tcr This study
pRWs1518a Ps1518a-lacZ transcriptional fusion, pRW50 containing truncated BPSS1518 upstream sequence from KHW,
type 1 deletion, Tcr
This study
pRWs1518b Ps1518b-lacZ transcriptional fusion, pRW50 containing truncated BPSS1518 upstream sequence from KHW,
type 2 deletion, Tcr
This study
pRWvirA PvirA-lacZ transcriptional fusion, pRW50 containing virA upstream sequence from KHW, Tcr This study
pRWvirA1 PvirA1-lacZ transcriptional fusion, pRW50 containing truncated virA upstream sequence from KHW, type 1 deletion, Tcr This study
pRWtssM PtssM-lacZ transcriptional fusion, pRW50 containing tssM upstream sequence from KHW, Tcr This study
aAbbreviations: Apr ampicillin resistant, Kmr kanamycin resistant, Tcr tetracycline resistant, Tmr trimethoprim resistant.
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identification numbers NC_006350.1 and NC_006351.1)
as the annotated reference genome. The number of reads
aligning to each genomic position on each strand was
calculated and normalized using RPKM ([reads/kb ofgene]/[million reads aligning to genome]). Differentially
expressed genes identified by the log2 ratio of the differ-
ential between the wildtype and ΔbsaN RPKMs. Only,
genes with a Δlog2 value of >1.5 and < −1.5 corre-
sponding to 3-fold up or down regulated genes with an
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this study.Measurement of B. pseudomallei gene expression by
qRT- PCR
Expression of activated genes was confirmed by qRT-
PCR of RNA prepared from bacteria grown in acidified
RPMI. Gene repression was difficult to observe under
these conditions; RNA for qRT-PCR analysis was there-
fore prepared from infected RAW264.7 cells using the
following procedure: RAW264.7 cells (5 × 105 cells/well)
were seeded and grown overnight in DMEM medium in
12 well plates. RAW264.7 cells were transferred to RPMI
medium prior to infection and infected at MOI of 100:1.
Bacterial RNA was isolated from infected RAW264.7 cells
4 hours post infection using TRIzol and PureLink RNA
mini-kit (Invitrogen). cDNA was synthesized using 1 μg of
RNA and the High Capacity Reverse Transcription Re-
agent Kit (Applied Biosystems). Transcripts were quan-
tified using GoTaq qPCR Master Mix (Promega) in a
BioRad iQ5 machine. Real-time PCR primers are listed
in Additional file 1: Table S4. Relative RNA level of a
particular gene in mutant strains was normalized to that
of wild type using the 2−ΔΔCt method with 16S rRNA or
recA as reference gene [55].Mapping transcriptional start sites
The transcriptional start (+1) sites of the promoters were
mapped by RNA ligase-mediated rapid amplification of
cDNA ends (RLM-RACE) [56]. The RLM-RACE was
performed using GeneRacer Kit (Invitrogen) according
to manufacturer’s instructions. The B. pseudomallei RNA
was isolated as described previously [14].Sequence motif predication and database search of
motifs in the B. pseudomallei KHW genome
150 base pairs of nucleotide sequence upstream of the
transcriptional starts of each gene was submitted to
the bioinformatics tool – MEME (http://meme.nbcr.net/
meme/cgi-bin/meme.cgi) for prediction of DNA motifs
[57]. The motif with the highest statistical significance
(lowest E-value) was chosen and its data – in Position-
Specific Probability Matrix format was submitted to MAST
(http://meme.nbcr.net/meme/cgi-bin/mast.cgi) to search
for the best matching positions in the upstream sequences
of B. pseudomallei KHW genes [58].Statistical analysis
Results were presented as mean ± standard deviation.
Student’s t-test was used to find the significant differ-
ences between the means, defined as when p < 0.05 (*)
and p < 0.01 (**).Additional file
Additional file 1: Materials and Methods. Table S1. Summary of
Illumina sequencing. Table S2. β-galactosidase activities in E coli DH5α
strain containing transcriptional promoter-lacZ fusions and arabinose-
inducible bsaN and bicA or empty vector. Table S3. List of additional
plasmids used in this study. Table S4. List of Real-Time PCR primers for
this study. Figure S1. Secretion of BopC. KHW and ΔbsaM mutant were
grown in acidic LB broth for 3 hours. Total protein from the bacterial
culture supernatant was precipitated and protein concentration was
normalized with respect to the optical density (OD600) of the bacterial
cultures. Proteins on membranes were probed with rabbit polyclonal
antibodies to BopC and BopE. Figure S2. (A) Intracellular replication of
B. pseudomallei KHW and mutants in RAW264.7 cells. Cells were infected
at an MOI of 0.1:1. Intracellular bacterial loads were quantified at 2 and
8 h post infection by plate counting. (B) Cytotoxicity of B. pseudomallei
KHW and mutants against RAW264.7 cells. Cells were infected at an
MOI of 100:1. Cytotoxicity was quantified at 8 h post infection by LDH
release assay. *p < 0.05. Figure S3. Secretion and function of BsaN
controlled proteins. A. Secretion of BPSS1513 in strain KHW. Proteins
were separated on 12% polyacrylamide gels, transferred to PVDF
membranes and probed with a mouse monoclonal antibody to HA or
rabbit polyclonal antibody to BopE. P: pellet; S: supernatant. B. Intracellular
replication of B. pseudomallei KHW and Δ(BPSS1513-folE) mutant in
RAW264.7 cells at 2 h and 8 h (MOI of 10:1) or C. 2 h and 24 h after
infection at an MOI of 0.1:1. Intracellular bacterial loads were quantified
by plate counting. D. Cytotoxicity of B. pseudomallei KHW and
Δ(BPSS1513-folE) mutant against RAW264.7 cells. Cells were infected at
an MOI of 100:1. Cytotoxicity was quantified at 8 h post infection by
LDH release assay. E. MNGC formation of cells infected with B. pseudomallei
wild-type (WT) strain KHW and F. Δ(BPSS1513-1514) mutant at an
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